Role of NF-κB/Snail/RKIP loop in the response of tumor cells to photodynamic therapy

Lasers in Surgery and Medicine

Volumn 43, Issue 7, 2011, Pages 575-585

  Rapozzi, Valentina ^a   Umezawa, Kazuo ^b   Xodo, Luigi E ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b KEIO UNIVERSITY   (Japan)

Author keywords

B78 H1 cells; DHMEQ; NF B; nitric oxide; PDT; pheophorbide a; RKIP; snail

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PHEOPHORBIDE; PHEOPHORBIDE ALPHA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CELL ASSAY; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; LIGHT EXPOSURE; MELANOMA CELL; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR ESCAPE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHLOROPHYLL; DOSE-RESPONSE RELATIONSHIP, DRUG; MELANOMA, AMELANOTIC; MICE; NF-KAPPA B; NITRIC OXIDE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 80052066352     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21095     Document Type: Article

References (67)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q,. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905. (Pubitemid 28304157)
2. Oleinick NL, Morris RL, Belichenko I,. The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem Photobiol Sci 2002; 1: 1-21. (Pubitemid 37069701)
3. Piette J, Volanti C, Vantieghem A, Matroule JY, Habraken Y, Agostinis P,. Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem Pharmacol 2003; 66: 1651-1659. (Pubitemid 38373358)
4. Moor ACE,. Signaling pathways in cell death and survival after photodynamic therapy. J Phochem Photobiol B Biol 2000; 57: 1-13.
5. Ryter SW, Gomer CJ,. Nuclear factor kB binding activity in mouse L1210 cells following photophrin II-mediated photosensitization. Photochem Photobiol 1993; 58: 753-756.
6. Matroule JY, Bonizzi G, Morliere P, Paillous N, Santus R, Bours V, Piette J,. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kB through the interleukin-1 receptor-dependent signaling pathway. J Biol Chem 1999; 275: 2988-3000. (Pubitemid 29075386)
7. Matroule JY, Volanti C, Piette J,. NF-kB in photodynamic therapy: Discrepancies of a master regulator. Photochem Photobiol 2006; 82: 1241-1246. (Pubitemid 44702003)
8. Kulikova L, Mikes J, Hyzdalova M, Palumbo G, Federocko P,. NF-kB is not directly responsible for photoresistance induced by fractionated light delivery in HT-29 colon adenocarcinoma cells. Photochem Photobiol 2010; 86: 1285-1293.
9. Ferrario A, von Tiehl K, Wong S, Luna M, Gomer CJ,. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy mediated tumor response. Cancer Res 2002; 62: 3956-3961. (Pubitemid 34791059)
10. Hendrickx N, Volanti C, Moens U, Seternes OM, de Witte P, Vandenheede RJ, Piette J, Agostinis P,. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J Biol Chem 2003; 278: 52231-52239. (Pubitemid 38035811)
11. Volanti C, Hendrickx N, Van Lint J, Matroule JY, Agostinis P, Piette J,. Distinct transduction mechanisms of cyclooxygenase-2 gene activation in tumour cells after photodynamic therapy. Oncogene 2005; 24: 2981-2991. (Pubitemid 40675529)
12. Ferrario A, von Tiehl KF, Wong S, Rucker N, Schwartz MA, Gill PS, Gomer CJ,. Anti-angiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 2000; 60: 4066-4069. (Pubitemid 30636586)
13. Ferrario A, Chantrain CF, von Thiel KF, Buckley S, Rucker N, Shalinsky DR, Shimada H, DeClerck YA, Gomer CJ,. The matrix metalloproteinase inhibitor Prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 2004; 64: 2328-2332. (Pubitemid 38523882)
14. Ferrario A, Rucker N, Wong S, Luna M, Gomer CJ,. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res 2007; 67: 4989-4995. (Pubitemid 46910208)
15. Ferrario A, Fisher A, Rucker N, Gomer CJ,. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 2005; 65: 9473-9478. (Pubitemid 41508016)
16. Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y, Fulda S, Agostinis P, Piette J,. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. Biochem Pharmacol 2011; 81: 606-616.
17. Luna M, Wong S, Ferrario A, Gomer CJ,. Cyclooxygenase-2 expression induced by Photofrin photodynamic therapy involves the p38 MAPK pathway. Phochem Photobiol 2008; 84: 509-514. (Pubitemid 351424033)
18. Gupta S, Ahmad N, Mukhtar H,. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res 1998; 58: 1785-1788. (Pubitemid 28217446)
19. Korbelik M, Parkins CS, Shibuya H, Cecic I, Stratford MR, Chaplin DJ,. Nitric oxide production by tumour tissue: Impact on the response to photodynamic therapy. Br J Cancer 2002; 82: 1835-1843.
20. Di Venosa G, Perotti C, Fukuda H, Batlle A, Casas A,. Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity. J Photochem Photobiol B 2005; 80: 195-202. (Pubitemid 41150648)
21. Yamamoto F, Ohgari Y, Yamaki N, Kitajima S, Shimokawa O, Matsui H, Taketani S,. The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells. Biochem Biophys Res Commun 2007; 353: 541-546. (Pubitemid 46048703)
22. Reeves KJ, Reed MWR, Brown NJ,. Is nitric oxide important in photodynamic therapy? J Photochem Photobiol B 2009; 95: 141-147.
23. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S,. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92: 4392-4396.
24. Tozer GM, Everett SA,. Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects. Clin Oncol 1997; 9: 282-293. (Pubitemid 27480627)
25. Marshall HE, Stamler JS,. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 2001; 40: 1688-1693.
26. Aggarwal BB,. Nuclear factor-kappa B: The enemy within. Cancer Cell 2004; 6: 203-208.
27. Barbera MJ, Puig I, Dominiguez D, Julien-Grille S, Guaita-Esteruelas S, Peirõ S, Baulida J, Francí C, Dedhar S, Larue L, García de Herreros A,. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 2004; 23: 7345-7354. (Pubitemid 39382137)
28. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A, Larue L,. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007; 26: 7445-7456. (Pubitemid 350158710)
29. Nieto MA,. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166.
30. Peinado H, Portillo F, Cano A,. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004; 48: 365-375. (Pubitemid 39360388)
31. Miyoshi A, Kitajima Y, Kido S, Shimonishi T, Matsuyama S, Kitahara K, Miyazaki K,. Snail accelerates cancer invasion by upregulating MMP expression and is association with poor prognosis of hepatocellular carcinoma. Br J Cancer 2005; 92: 252-258. (Pubitemid 40343137)
32. Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC,. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 2008; 27: 2243-2248. (Pubitemid 351483382)
33. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W,. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999; 401: 173-177. (Pubitemid 29436321)
34. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolck W, Sedivy JM,. Raf kinase inhibitor protein interacts with NF-kappa B inducing kinase and TAK1 and inhibits NF-kappa B activation. Mol Cell Biol 2001; 212: 7207-7217. (Pubitemid 32953475)
35. Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC,. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004; 279: 17515-17523. (Pubitemid 38560515)
36. Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z,. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008; 6: 917-928.
37. Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E, Yeung KC,. RKIP inhibits NF-kB in cancer cells by regulating upstream signaling components of the IkB kinase complex. FEBS Lett 2010; 584: 662-668.
38. Baritaki S, Yeung K, Palladino M, Berenson J, Bonavida B,. Pivotal roles of Snail inhibition and RKIP induction by the proteosome inhibitor NPI-0052 in tumor cell chemosensitization. Cancer Res 2009; 69: 8376-8385.
39. Baritaki S, Chapman A, Yeung K, Spandidos DA, Palladino M, Bonavida B,. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteosome inhibitor NPI-0052; pivotal roles of Snail repression and RKIP induction. Oncogene 2009; 28: 3573-3585.
40. Wu. K, Bonavida B,. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 2009; 29: 241-254.
41. Suzuki Y, Sugiyama C, Ohno O, Umezawa K,. Preparation and biological activities of optically active dehydroxymethylepoxyquinomicin, a novel NF-kB inhibitor. Tetrahedron 2004; 60: 7061-7066. (Pubitemid 38942932)
42. Abmayr SM, Yao T, Parmely T, Workman JL,. Preparation of nuclear and cytoplasmic extracts from mammalian cells. Curr Protoc Mol Biol 2006; Chapter 12:Unit 12.1.
43. Bradford MM,. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
44. Matroule JY, Carthy CM, Granville DJ, Jolois O, Hunt DW, Piette J,. Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 2001; 20: 4070-4084. (Pubitemid 32681612)
45. Lee WY, Lim DS, Ko SH, Park YJ, Ryu KS, Ahn MY, Kim YR, Lee DW, Cho CW,. Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells. J Photochem Photobiol B 2004; 74: 119-126. (Pubitemid 39194114)
46. Tang PMK, Chan JYW, Au SWN, Kong SK, Tsui SKW, Waye MMY, Mak TC, Fong WP, Fung KP,. Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther 2006; 5: 1111-1116. (Pubitemid 44772223)
47. Rapozzi V, Miculan M, Xodo LE,. Evidence that photoactivated pheophorbide a causes in human cancer cells a photodynamic effect involving lipid peroxidation. Cancer Biol Ther 2009; 8: 1318-1327.
48. Rapozzi V, Zacchigna M, Biffi S, Garrovo C, Cateni F, Stebel M, Zorzet S, Bonora GM, Drioli S, Xodo LE,. Conjugated PDT drug: Photosensitizing activity and tissue distribution of PEGylated pheophorbide a. Cancer Biol Ther 2010; 10: 471-482.
49. Hajri A, Coffy S, Vallat F, Evrard S, Marescaux J, Aprahamian M,. Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo. Br J Surg 1999; 86: 899-906. (Pubitemid 29333014)
50. Hajri A, Wack S, Meyer C, Smith MK, Leberquier C, Kedinger M, Aprahamian M,. In vitro and in vivo efficacy of Photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol 2002; 75: 140-148.
51. Evrard S, Keller P, Hajri A, Balbon G, Mendoza-Burgos L, Damge C, Marescaux J, Aprahamian M,. Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg 1994; 81: 1185-1189. (Pubitemid 24262952)
52. Henderson BW, Dougherty TJ,. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-157.
53. Buytaert E, Dewaele M, Agostinis P,. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007; 1776: 86-107. (Pubitemid 47332075)
54. Yamamoto M, Horie R, Takeiri M, Kozawa I, Umezawa K,. Inactivation of NF-kappaB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues. J Med Chem 2008; 51: 5780-5788.
55. Karin M,. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 1999; 18: 6867-6874.
56. Traenckner EB, Pahl HL, Henkel T, Schmidt N, Wilk S, Baeuerle PA,. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 1995; 14: 2876-2883.
57. Karin M, Ben-neriah Y,. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-663. (Pubitemid 30365393)
58. Tatetsu H, Okuno Y, Nakamura M, Matsuno F, Sonoki T, Taniguchi I, Uneda S, Umezawa K, Mitsuya H, Hata H,. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kB inhibitor, induces apoptosis in multiple myeloma cells in an IkBα-independent manner. Mol Cancer Ther 2005; 4: 1114-1120. (Pubitemid 41079105)
59. Bonizzi G, Karin M,. The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-288. (Pubitemid 38610351)
60. Schoonbroodt S, Piette J,. Oxidative stress interference with the nuclear factor-kappaB activation pathways. Biochem Pharmacol 2000; 60: 1075-1083.
61. Volanti C, Matroule JY, Piette J,. Involvement of oxidative stress in NF-kB activation in endothelial cells treated by photodynamic therapy. Photochem Photobiol 2002; 75: 36-45.
62. Huerta S, Chilka S, Bonavida B,. Nitric oxide donors: Novel cancer therapeutics (Review). Int J Oncol 2008; 33: 909-927.
63. Davies KM, Wink DA, Saavedra JE, Keefer LK,. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J Am Chem Soc 2001; 123: 5473-5481. (Pubitemid 32888516)
64. Gomer CJ, Ferrario A, Luna M, Rucker N, Wong S,. Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 2006; 38: 516-521.
65. Parkins CS, Dennis MF, Strtatford MR, Hill SA, Hill DJ,. Ischemia reperfusion injury in tumors: The role of oxygen radicals and nitric oxide. Cancer Res 1995; 55: 6026-6029.
66. Peiro S, Escriva M, Puig I, Barberà MJ, Dave N, Herranz N, Larriba MJ, Takkunen M, Francí C, Muñoz A, Virtanen I, Baulida J, García de Herreros A,. Snail transcriptional repressor binds to its own promoter and controls its expression. Nucleic Acids Res 2006; 34: 2077-2084. (Pubitemid 44321291)
67. Keller ET, Zheng F, Brennan M,. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004; 68: 1049-1053. (Pubitemid 39094269)